Xeraya Capital — 2020 Investments
3 investments dated 2020 · listed companies and verified rows first · show all
Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, GB
Co-investorsCambridge Innovation CapitalFuture Planet CapitalQVenturesAmadeus Capital PartnersIDO InvestmentsLegal & General+3 more
A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.
BiotechHealthtech
Co-investorsFrazier Life SciencesHighlight CapitalMRL Ventures FundAmgen VenturesBlackRockBlackstone Life Sciences+5 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




